<!DOCTYPE html>
<html lang="en">
<head>
    <meta charset="UTF-8">
    <meta name="viewport" content="width=device-width, initial-scale=1.0">
    <title>BELEODAQ (belinostat) for injection - for Healthcare Professionals (HCPs)</title>
    <meta name="description" content="In the next round against relapsed or refractory PTCL, fight on with BELEODAQ. It is an HDAC inhibitor available for relapsed/refractory PTCL.">
    <!-- Google fonts -->
    <link rel="preconnect" href="https://fonts.gstatic.com">
    <link href="https://fonts.googleapis.com/css2?family=Open+Sans:wght@400;700&family=Raleway:wght@700&display=swap" rel="stylesheet">
    <!-- CSS Reset -->
    <link rel="stylesheet" href="style/reset.css">
    <!-- Stylesheet -->
    <link rel="stylesheet" href="style/style.css">
</head>
<body>
    <!-- Header -->
    <header class="header">
        <!-- Indications and Usage -->
        <div class="indications">
            <h5 class="indications__title">Indications and Usage</h5>
            <p class="indications__body copyright">BELEODAQ is a histone deacetylase inhibitor indicated for the treatment of adult patients with relapsed or refractory (R/R) peripheral T-cell lymphoma (PTCL). This indication is approved under accelerated approval based on tumor response rate and duration of response. An improvement in survival or disease-related symptoms has not been established. Continued approval for this indication may be contingent upon verification and description of clinical benefit in the confirmatory trial.</p>
        </div>
        <!-- Navigation -->
        <nav class="nav">
            <!-- Logo -->
            <a class="nav__logo" href="#">
                <img src="https://beleodaq.com/hcp/wp-content/uploads/2019/04/logonew.png" alt="BELEODAQ® (belinostat) for injection: For injection in the treatment of relapsed or refractory PTCL">
            </a>
            <!-- Header Buttons -->
            <div class="nav__buttons">
                <!-- Site Buttons (redirecting to other parts of site) -->
                <ul class="site-buttons">
                    <li>
                        <a class="site-buttons__button copyright" href="#">
                            Important Safety Information
                        </a>
                    </li>
                    <li>
                        <a class="site-buttons__button copyright"
                        href="#">
                           Prescribing Information
                        </a>
                    </li>
                    <li>
                        <a class="site-buttons__button button--orange copyright"href="#">
                           Patient Site
                        </a>
                    </li>
                </ul>
                <!-- Nav Links and Dropdown Menus -->
                <ul class="navlinks">
                    <li class="navlinks__link">
                        <a class="navlinks__link--default">PTCL Overview</a>
                    </li>
                    <li class="navlinks__link">
                        <a class="navlinks__link--default">About Beleodaq</a>
                    </li>
                    <li class="navlinks__link">
                        <a class="navlinks__link--default">Efficacy</a>
                        <ul class="dropdown">
                            <li class="dropdown__item">
                                <a href="" class="dropdown__item--default">
                                    Study design
                                </a>
                            </li>
                            <li class="dropdown__item">
                                <a href="" class="dropdown__item--default">
                                    Baseline Characteristics
                                </a>
                            </li>
                            <li class="dropdown__item">
                                <a href="" class="dropdown__item--default">
                                    Response Rate
                                </a>
                             </li>
                            <li class="dropdown__item">
                                <a href="" class="dropdown__item--default">
                                    Duration of Response
                                </a>
                            </li>
                        </ul>
                    </li>
                    <li class="navlinks__link">
                        <a class="navlinks__link--default">Safety & Tolerability</a>
                        <ul class="dropdown">
                            <li class="dropdown__item">
                                <a href="" class="dropdown__item--default">
                                    Adverse Reactions
                                </a>
                            </li>
                            <li class="dropdown__item">
                                <a href="" class="dropdown__item--default">
                                    Tolerability
                                </a>
                            </li>
                        </ul>
                    </li>
                    <li class="navlinks__link">
                        <a class="navlinks__link--default">Dosing & Administration</a>
                        <ul class="dropdown">
                            <li class="dropdown__item">
                                <a href="" class="dropdown__item--default">
                                    Dosing Schedule
                                </a>
                            </li>
                            <li class="dropdown__item">
                                <a href="" class="dropdown__item--default">
                                    Dose Modifications
                                </a>
                            </li>
                        </ul>
                    </li>
                    <li class="navlinks__link">
                        <a class="navlinks__link--default">Access & Resources</a>
                        <ul class="dropdown">
                            <li class="dropdown__item">
                                <a href="" class="dropdown__item--default">
                                    STAR
                                </a>
                            </li>
                            <li class="dropdown__item">
                                <a href="" class="dropdown__item--default">
                                    Resources
                                </a>
                            </li>
                        </ul>
                    </li>
                    <li class="navlinks__link">
                        <a class="navlinks__link--default">Contact Us</a>
                    </li>
                </ul>
            </div>
        </nav>
    </header>
    <!-- Main -->
    <main>
        <!-- Carousel -->
        <section class="carousel" aria-label="Gallery">
            <ol class="carousel__viewport">
                <li class="carousel__slide" id="carousel__slide1">
                    <h1>AN IMPORTANT PIECE</h1>
                    <h4>WHEN CONSIDERING A TREATMENT FOR ADULT PATIENTS WITH PTCL AT FIRST RELAPSE</h4>
                    <a href="#">Learn More</a>
                </li>
                <li class="carousel__slide" id="carousel__slide2">
                    <h2>BELEODAQ</h2>
                    <h4>EXCEEDS THE ​TARGET ​RESPONSE RATE CONSIDERED CLINICALLY RELEVANT​ FOR THE BELIEF TRIAL</h4>
                    <a href="#">Efficacy</a>
                </li>
                <li class="carousel__slide" id="carousel__slide3">
                    <h3>MOST ​PATIENTS IN THE BELIEF TRIAL TOLERATED THE TARGET DOSE OF BELEODAQ​</h3>
                    <a href="#">Safety & Tolerability</a>
                </li>
                <li class="carousel__slide" id="carousel__slide4">
                    <h4>Be Ready for Relapse and Refractory Peripheral T-Cell Lymphoma from the onset. Consider how BELEODAQ  may fit into your patient's treatment plan at first relapse.</h4>
                    <a href="#">Learn More</a>
                </li>
            </ol>
        </section>
        <!-- Question Buttons -->
        <div class="question-buttons">
            <a href="" class="question_buttons__button">
                Which patients are right for BELEODAQ?
            </a>
            <a href="" class="question_buttons__button">
                How have patients responded to BELEODAQ?​
            </a>
            <a href="" class="question_buttons__button">
                How will my patient tolerate BELEODAQ?
            </a>
            <a href="" class="question_buttons__button">
                Does BELEODAQ dosing fit my patient’s routine?
            </a>
            <a href="" class="question_buttons__button">
                When should I consider using BELEODAQ for my patient?
            </a>
        </div>
    </main>
    <!-- ISI -->
    <footer>
        <section class="isi">
        <h5 class="isi__header">Select Important Safety Information</h5>
        <p class="isi__body"><span class="isi__body--bold">Warnings and Precautions</span>
            BELEODAQ can cause thrombocytopenia, leukopenia (neutropenia and lymphopenia), and/or anemia; monitor blood counts weekly during treatment, and modify dosage as necessary.</p>
        </section>
        <a class="isi-button" href="#">
            See More <span>&uarr;</span>
        </a>
    </footer>
</body>
</html>